BMI View: Multinational pharmaceutical companies have felt the pressure in Canada’s drug market due to the government’s cost-containment policy and the significant number of blockbuster drug patent expiries; however, there are still many opportunities for multinational drugmakers in Canada as per capita consumption in Canada is still one of the highest in the world and the Canadian economy remains relatively healthy compared with most developed states. In addition, the government is still looking for ways to attract pharmaceutical companies to its biotechnology potential and capabilities. Headline Expenditure Projections ? Pharmaceuticals: CAD25.8bn (US$25.6bn) in 2012 to CAD25.7bn (US$24.7bn) in 2013; -0.3% …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=113302.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/canada-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment